Streamlining the supply chain: insights on raw material sourcing and quality by design
Year: 2025
Type: article
Abstract: “...maintaining quality by design is especially difficult in CGT because we have variable starting material. Abi Pinchbeck, Editor, BioInsights, speaks to Lara Silverman, Founder and Principal Consultant, LIS BioConsulting, discussing the critical role of supply chain management in early-stage cell and gene therapy companies, including raw and starting material sourcing strategies. They cover the importance of QbD in advanced therapies, regulatory expectations surrounding the supply chain, and how evolving technologies can help drive down manufacturing costs.
Source: Cell and Gene Therapy Insights
Author: Lara Silverman
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: hybrid
OpenAlex ID: W4417330302
FWCI:
Cites:
Cited by:
Related to: